EMMA vs EME: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

EME has stronger fundamentals based on our AI analysis.

EMMA
Emmaus Life Sciences, Inc.
STRONG SELL
95%
Confidence
VS
EME
EMCOR Group, Inc.
STRONG BUY
85%
Confidence

EMMA vs EME Fundamental Comparison

Metric EMMA EME
Revenue $8.6M $17.0B
Net Income $-5.5M $1.3B
Net Margin -64.4% 7.5%
ROE N/A 34.6%
ROA -26.7% 13.7%
Current Ratio 0.07x 1.22x
Debt/Equity N/A 0.00x
EPS $-0.09 $28.19

Green = Better metric | Red = Weaker metric

View Full EMMA Analysis →
View Full EME Analysis →

You Might Also Compare

EMMA vs AAPL EME vs MSFT EMMA vs GOOGL EME vs AMZN

EMMA vs EME: Frequently Asked Questions

Is EMMA or EME a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), EME has stronger fundamentals. EMMA is rated STRONG SELL (95% confidence) while EME is rated STRONG BUY (85% confidence). This is not investment advice.

How does EMMA compare to EME fundamentally?

Emmaus Life Sciences, Inc. has ROE of N/A vs EMCOR Group, Inc.'s 34.6%. Net margins are -64.4% vs 7.5% respectively.

Which stock pays higher dividends, EMMA or EME?

EMMA has a dividend yield of N/A or no dividend while EME has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in EMMA or EME for long term?

For long-term investing, consider that EMMA has STRONG SELL rating with 95% confidence, while EME has STRONG BUY rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about EMMA vs EME?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EMMA vs EME, the AI consensus favors EME based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.